Lupin Stock Screener | Share Price & Fundamental Analysis
LUPIN
Pharmaceuticals
Share Price NSE
₹2219.40
▼
-9.30 (-0.42%)
Share Price BSE
₹2219.70
▼
-8.70 (-0.39%)
Track Lupin share price live with TickJournal's free stock screener.
Analyze Lupin share price history trends and compare 52-week high low
levels.
Calculate LUPIN stock fair value using fundamental analysis and view live share price charts.
Determine Lupin share intrinsic value and compare it with current LUPIN share price.
Record your Lupin trades in TickJournal's free trading journal and track your portfolio performance.
Lupin Market Cap
₹100,463.76 Cr.
LUPIN P/E Ratio (TTM)
23.23
Lupin P/B Ratio
5.14
EPS (TTM)
₹71.95
Dividend Yield
0.54%
Debt to Equity
0.27
LUPIN 52 Week High
₹2247.50
Lupin 52 Week Low
₹1851.80
Operating Margin
22.00%
Profit Margin
13.92%
LUPIN Revenue (TTM)
₹5,619.00
EBITDA
₹1,273.00
Net Income
₹782.00
Total Assets
₹29,205.00
Total Equity
₹17,294.00
Lupin Share Price History - Stock Screener Chart
Screen LUPIN historical share price movements with interactive charts. Analyze price trends and patterns.
Lupin Company Profile - Fundamental Screener
Screen Lupin company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for LUPIN shares.
Lupin is a global pharmaceutical company producing branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. Founded in 1983, it operates in over 100 markets, specializing in cardiovascular, diabetology, asthma, pediatric, central nervous system, gastrointestinal, anti-infective, and NSAID therapies. Lupin is a leader in anti-TB and cephalosporins segments. The...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
M D Gupta
ISIN
INE326A01037
Website
https://www.lupin.com/
Lupin Balance Sheet Screener
Screen LUPIN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 29,205 | 23,997 | 22,956 | 21,821 | 23,610 | 24,984 | 27,949 | 26,305 | 26,607 | 22,625 |
| Current Assets | 16,799 | 13,448 | 12,451 | 12,458 | 13,986 | 15,413 | 13,854 | 12,210 | 11,953 | 9,887 |
| Fixed Assets | 9,719 | 8,878 | 8,355 | 7,382 | 7,881 | 7,938 | 11,087 | 10,362 | 11,033 | 8,717 |
| Liabilities | ||||||||||
| Total Liabilities | 29,205 | 23,997 | 22,956 | 21,821 | 23,610 | 24,984 | 27,949 | 26,305 | 26,607 | 22,625 |
| Current Liabilities | 2,949 | 1,122 | 1,148 | 1,101 | 1,316 | 3,178 | 8,030 | 7,593 | 6,955 | 6,368 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 17,294 | 14,374 | 12,543 | 12,222 | 13,858 | 12,581 | 13,789 | 13,617 | 13,532 | 11,196 |
| Share Capital | 91 | 91 | 91 | 91 | 91 | 91 | 91 | 90 | 90 | 90 |
| Reserves & Surplus | 17,112 | 14,199 | 12,374 | 12,062 | 13,712 | 12,446 | 13,652 | 13,487 | 13,407 | 11,073 |
Lupin Income Statement Screener - Profit & Revenue Analysis
Screen Lupin income statement and profit fundamentals.
Analyze LUPIN quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Lupin share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5,619 | 6,243 | 6,921 | 7,215 | 4,924 | 5,582 | 5,539 | 5,672 | 4,368 | 4,765 | 4,980 | 5,109 | 3,880 | 3,610 | 4,106 |
| Expenses | 4,346 | 4,541 | 4,706 | 5,332 | 3,964 | 4,359 | 4,332 | 4,412 | 3,852 | 3,958 | 4,121 | 4,160 | 3,615 | 3,512 | 3,693 |
| EBITDA | 1,273 | 1,702 | 2,215 | 1,883 | 960 | 1,223 | 1,207 | 1,261 | 515 | 807 | 859 | 950 | 265 | 98 | 414 |
| Operating Profit % | 22.00% | 26.00% | 31.00% | 25.00% | 19.00% | 21.00% | 21.00% | 21.00% | 11.00% | 17.00% | 17.00% | 18.00% | 6.00% | 3.00% | 10.00% |
| Depreciation | 393 | 299 | 317 | 313 | 457 | 248 | 257 | 272 | 264 | 235 | 248 | 257 | 327 | 193 | 204 |
| Interest | 89 | 92 | 108 | 115 | 71 | 68 | 71 | 67 | 93 | 86 | 81 | 74 | 42 | 43 | 55 |
| Profit Before Tax | 896 | 1,416 | 2,007 | 1,522 | 498 | 993 | 1,055 | 1,071 | 259 | 559 | 630 | 736 | -85 | 2 | 210 |
| Tax | 114 | 194 | 522 | 342 | 130 | 188 | 195 | 212 | 16 | 106 | 134 | 117 | 427 | 89 | 75 |
| Net Profit | 782 | 1,222 | 1,485 | 1,181 | 368 | 806 | 860 | 859 | 242 | 453 | 495 | 619 | -512 | -87 | 135 |
| EPS | 16.93 | 26.70 | 32.36 | 25.74 | 7.89 | 17.58 | 18.70 | 18.75 | 5.19 | 9.94 | 10.76 | 13.47 | -11.40 | -1.96 | 2.85 |
Lupin Cash Flow Screener - Liquidity Fundamentals
Screen LUPIN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 3,000 | 3,648 | 1,897 | 367 | 1,822 | 1,469 | 1,666 | 1,751 | 4,114 | -382 |
| Investing Activities | -4,172 | -1,712 | -1,287 | 1,292 | -1,240 | 1,107 | -3,283 | 470 | -2,527 | -6,769 |
| Financing Activities | 1,732 | -2,184 | -337 | -1,572 | -1,885 | -891 | 744 | -1,492 | 433 | 5,836 |
| Net Cash Flow | 560 | -248 | 273 | 87 | -1,303 | 1,685 | -872 | 729 | 2,019 | -1,315 |
Lupin Shareholding Pattern Screener
See Lupin shareholding pattern with promoter, FII, and DII holdings.
Check Lupin promoter holding and ownership changes for LUPIN on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 46.89% | 46.90% | 46.90% | 46.92% | 46.95% | 46.96% | 46.98% | 47.01% |
| FII Holding | 21.49% | 20.49% | 21.25% | 21.46% | 22.04% | 21.50% | 19.32% | 18.28% |
| DII Holding | 25.58% | 26.55% | 25.56% | 25.41% | 24.74% | 25.09% | 26.78% | 27.76% |
| Govt Holding | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public Holding | 5.10% | 5.12% | 5.23% | 5.10% | 5.17% | 5.29% | 5.65% | 5.70% |
| Other Holding | 0.93% | 0.94% | 1.05% | 1.10% | 1.10% | 1.15% | 1.26% | 1.23% |
| Shareholder Count | 288,931 | 280,256 | 286,604 | 283,210 | 281,988 | 279,280 | 288,537 | 280,248 |
Lupin Share Dividend Screener - Share Yield Analysis
Check Lupin dividend history with payout and yield data.
View Lupin dividend details including ex-dates and amounts for LUPIN stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹12.00 | 0.55% |
| 2024-March | ₹8.00 | 0.39% |
| 2023-March | ₹4.00 | 0.25% |
| 2022-March | ₹4.00 | 0.61% |
| 2021-March | ₹6.50 | 0.87% |
| 2020-March | ₹6.00 | 0.59% |
| 2019-March | ₹5.00 | 0.85% |
| 2018-March | ₹5.00 | 0.68% |
| 2017-March | ₹7.50 | 1.02% |
Lupin Stock Index Membership
See which indices include Lupin stock.
Check LUPIN index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Lupin Market Events Screener - Corporate Actions
Get Lupin corporate actions including splits, bonuses, and buybacks.
Check Lupin stock events that may affect LUPIN share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 2.72% |
| 2025-11-06 | 2025-11-06 | Quarterly Result Announcement | NA | 2.76% |
| 2025-08-11 | 2025-08-11 | Annual General Meeting | NA | 1.23% |
| 2025-08-05 | 2025-08-05 | Quarterly Result Announcement | NA | -2.52% |
| 2025-07-25 | 2025-07-25 | Dividend | ₹ 12.00 /share | -5.80% |
| 2025-05-14 | 2025-05-14 | Quarterly Result Announcement | NA | -2.12% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | 1.65% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | 0.66% |
| 2024-08-02 | 2024-08-02 | Annual General Meeting | NA | 9.82% |
| 2024-07-16 | 2024-07-16 | Dividend | ₹ 8.00 /share | 10.68% |
| 2023-07-14 | 2023-07-14 | Dividend | ₹ 4.00 /share | 27.11% |
| 2022-07-14 | 2022-07-15 | Dividend | ₹ 4.00 /share | -5.87% |
| 2021-07-27 | 2021-07-28 | Dividend | ₹ 6.50 /share | -8.30% |
Lupin Competitors Screener - Peer Comparison
Screen LUPIN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 407,287 | 37.56 | 54,729 | 9.71% | 10,980 | 52.49 |
| Divis Laboratories | 163,754 | 66.27 | 9,712 | 18.67% | 2,191 | 48.87 |
| Torrent Pharmaceuticals | 138,018 | 64.55 | 11,539 | 6.99% | 1,911 | 59.36 |
| Cipla | 107,555 | 23.69 | 28,410 | 7.12% | 5,291 | 35.86 |
| Dr Reddys Laboratories | 105,839 | 19.26 | 33,741 | 16.73% | 5,725 | 58.24 |
| Lupin | 100,464 | 23.23 | 22,910 | 13.74% | 3,306 | 56.93 |
| Zydus Life Science | 91,034 | 18.43 | 23,511 | 18.55% | 4,615 | 51.32 |
| Mankind Pharma | 85,058 | 47.59 | 12,744 | 20.90% | 2,007 | 42.02 |
| Aurobindo Pharma | 66,537 | 19.29 | 32,346 | 9.43% | 3,484 | 45.13 |
| Alkem Laboratories | 64,595 | 29.06 | 13,458 | 3.70% | 2,216 | 36.02 |
Lupin Company Announcements - News Screener
Screen LUPIN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| Announcement under Regulation 30 (LODR)-Newspaper Publication | View | |
| 2026-02-21 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-02-21 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-21 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2026-02-21 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2026-02-21 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2026-02-20 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2026-02-20 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-20 | Board Meeting Outcome for Outcome Of The Board Meeting For Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025. | View |
| 2026-02-20 | Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025. | View |
| 2026-02-18 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-02-18 | Settlement And License Agreement | View |
| 2026-02-17 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-02 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-02 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-01-28 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-28 | Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025. | View |
| 2026-01-27 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2026-01-23 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |